Literature DB >> 1936072

Metabolism of anti-herpes agent 5-(2-chloroethyl)-2'-deoxyuridine in mice and rats.

I Szinai1, Z Veres, K Ganzler, J Hegedus-Vajda, E De Clercq.   

Abstract

The enzymatic splitting and metabolic elimination of anti-viral agent 5-(2-chloroethyl)-2'-deoxyuridine [CEDU] have been studied. For elucidation of structures of metabolites, several different kinds of extraction, purification and spectroscopic methods were used (Extrelut LC, TLC, HPLC, MS, NMR, IR, UV and CD). For mass spectral analysis, various ionization techniques (EI, CI and FAB-MS) were performed as complementary methods. After oral administration of [14C]-CEDU to mice and rats, the parent compound, 5-(2chloroethyl) uracil [CEU] and hydroxylated CEU metabolites were isolated and identified from urine and faeces by the above mentioned methods. The CEDU showed rapid phosphorolysis in vitro with thymidine phosphorylase Km 41.0 +/- 5.0; and uridine phosphorylase Km 10.0 +/- 1.5. The cleavage of the N-glycosidic bond of the nucleoside analogue and a new metabolic pathway of CEDU [stereoselective oxidation of 5-(2-chloroethyl) uracil] was observed in both species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936072     DOI: 10.1007/BF03189949

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  Biotransformation of 5-(2-chloroethyl)-2'-deoxyuridine in male NMRI mice.

Authors:  I Szinai; E de Clercq
Journal:  Drug Metab Dispos       Date:  1989 Nov-Dec       Impact factor: 3.922

2.  5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo.

Authors:  B Rosenwirth; H Griengl; E Wanek; E De Clercq
Journal:  Antiviral Res       Date:  1985       Impact factor: 5.970

3.  Mutagenic and antimutagenic effects of 5-substituted 2'-deoxyuridines depending on the nature of the 5-substituent.

Authors:  H Marquardt; J Westendorf; A Schaefer; J Boldt; E De Clercq; H Marquardt
Journal:  Arzneimittelforschung       Date:  1988-12

4.  Microwave extraction. A novel sample preparation method for chromatography.

Authors:  K Ganzler; A Salgó; K Valkó
Journal:  J Chromatogr       Date:  1986-12-26

5.  Enzymatic cleavage of 5-substituted-2'-deoxyuridines by pyrimidine nucleoside phosphorylases.

Authors:  Z Veres; A Szabolcs; I Szinai; G Dénes; A Jeney
Journal:  Biochem Pharmacol       Date:  1986-03-15       Impact factor: 5.858

6.  Deoxyribosyl exchange reactions leading to the in vivo generation and regeneration of the antiviral agents (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5-ethyl-2'-deoxyuridine and 5-(2-chloroethyl)-2'-deoxyuridine.

Authors:  C Desgranges; E De Clercq; G Razaka; F Drouillet; I Belloc; H Bricaud
Journal:  Biochem Pharmacol       Date:  1986-05-15       Impact factor: 5.858

7.  [Isolation and identification of metabolites of 5-ethyl-2'-deoxyuridine from rat urine].

Authors:  R Kaul; B Hempel
Journal:  Arzneimittelforschung       Date:  1985

8.  5-(Haloalkyl)-2'-deoxyuridines: a novel type of potent antiviral nucleoside analogue.

Authors:  H Griengl; M Bodenteich; W Hayden; E Wanek; W Streicher; P Stütz; H Bachmayer; I Ghazzouli; B Rosenwirth
Journal:  J Med Chem       Date:  1985-11       Impact factor: 7.446

9.  Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine.

Authors:  Z Veres; I Szinai; A Szabolcs; K Ujszászy; G Dénes
Journal:  Drugs Exp Clin Res       Date:  1987

10.  Ocular penetration and efficacy of chloroethyldeoxyuridine against herpetic keratouveitis.

Authors:  P C Maudgal; E De Clercq; R Bernaerts; M Dieltiens; M Breemersch; L Van Eeckhoutte
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-10       Impact factor: 4.799

View more
  1 in total

1.  Collisionally-induced dissociation of substituted pyrimidine antiviral agents: mechanisms of ion formation using gas phase hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry.

Authors:  Amin M Kamel; Burnaby Munson
Journal:  J Am Soc Mass Spectrom       Date:  2007-05-10       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.